CIK 0001661059 · Non-accelerated filer<br>Smaller reporting company
NextCure, Inc.
Sign in to watch- Ticker
- NXTC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475231247
- Phone
- 240-399-4900
- Business address
- 2850 QUARRY LAKE DRIVE, SUITE 280, BALTIMORE, MD, 21209
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- SC 13G Stake Amended Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- SC 13G Stake Amended Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- 4 Open-market buy 10% owner bought 400,000 shares at $15.00 ($6,000,000)
- 4 Conversion 10% owner acquired 197,993 shares (conversion)
- 4 Open-market buy Director bought 50,000 shares at $15.00 ($750,000)
- 4 Open-market buy Director bought 350,000 shares at $15.00 ($5,250,000)
- 4 Open-market buy Director bought 125,000 shares at $15.00 ($1,875,000)
- 4 Open-market buy 10% owner bought 50,000 shares at $15.00 ($750,000)
- 4 Open-market buy Director bought 350,000 shares at $15.00 ($5,250,000)
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Bylaws or fiscal year change · Other events
- 424B4 Offering Prospectus
Page 18 of 20 · 400 filings